EJNMMI Research · 2018 · 31 citations · 20 references
MedicineNeurologyNeuroscienceBiomedical ImagingClinical NeuroscienceNeuroradiologyAcute Ischemic StrokeBrain ImagingCerebrovascular DiseasePositron Emission TomographyStrokeStroke ImagingCorticobasal SyndromeDiffusion Tensor Imaging MarkersIschemic Stroke PathophysiologyNeuroimaging Of Ischemic StrokeNeuroinflammatory MarkersNeurologic Pet ImagingTau HyperphosphorylationTau Uptake
The 18 F-THK-5351 radiotracer has been used to detect the in vivo tau protein distribution in patients with tauopathy, such as Alzheimer’s disease and corticobasal syndrome. In addition, 18 F-THK-5351 can also monitor neuroinflammatory process due to high affinity to astrogliosis. We aimed to explore 18 F-THK-5351 distribution patterns and characteristics in patients with recent ischemic stroke. Fifteen patients received 18 F-THK-5351 positron emission tomography (PET) and diffusion tensor imaging (DTI) approximately 3 months after ischemic stroke. A region of interest (ROI) was placed in the peri-ischemic area and was mirrored on the contralateral side as the control, and a proportional value was derived from the ratio of the peri-ischemic ROI value over the mirrored ROI value. Increased 18 F-THK-5351 retention was observed in the areas around and remote from the stroke location. The proportional 18 F-THK-5351 values were negatively correlated with the proportional fractional anisotropy values ( r = − 0.39, P = 0.04). 18 F-THK-5351 PET imaging provides a potential tool for in vivo visualization of the widespread ischemia-related changes associated with a microstructural disruption in recent ischemic stroke patients.
20
Classification and natural history of clinically identifiable subtypes of cerebral infarction
John Bamford, Peter Sandercock, Martin Dennis et al. · The Lancet · 1991 · 3.3K citations
Medicine, Neurology, Neurosurgery +16